Literature DB >> 10370922

Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network.

J Weeks1.   

Abstract

The assessment of outcomes is a major priority of the National Comprehensive Cancer Network (NCCN). To date, the NCCN's outcomes program has (1) made a systematic inventory of member institutions' existing data sources; (2) begun a collaborative project with the National Cancer Data Bank to compare specific surgical patterns of care in NCCN institutions with national norms; and (3) begun the creation of a prospective outcomes database within the NCCN. As the first step in the database initiative, five NCCN institutions participated in a pilot project in one disease, breast cancer, aimed at developing and testing techniques of data collection, aggregation, and analysis. Six more sites were added to the pilot program in 1998. As of September 1998, data on over 1,000 unique cases had been submitted to the database, with the number of additional cases expected to triple or quadruple within the ensuing 12 months. Future plans call for (1) further expansion of the breast cancer database, both in terms of the number of institutions participating and the scope of data being collected; (2) the addition of a second disease, non-Hodgkin's lymphoma, to the database; and (3) the establishment of partnerships with other organizations for whom the database might provide useful information, such as insurers, pharmaceutical and biotechnology firms, and regulatory and accrediting bodies.

Entities:  

Mesh:

Year:  1999        PMID: 10370922

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  16 in total

1.  A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.

Authors:  Caprice K Christian; Joyce Niland; Stephen B Edge; Rebecca A Ottesen; Melissa E Hughes; Richard Theriault; John Wilson; Charles A Hergrueter; Jane C Weeks
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.

Authors:  Lia M Halasz; Hajime Uno; Melissa Hughes; Thomas D'Amico; Elisabeth U Dexter; Stephen B Edge; James A Hayman; Joyce C Niland; Gregory A Otterson; Katherine M W Pisters; Richard Theriault; Jane C Weeks; Rinaa S Punglia
Journal:  Cancer       Date:  2016-04-18       Impact factor: 6.860

3.  Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?

Authors:  Yu-Ning Wong; Rebecca A Ottesen; Melissa E Hughes; Joyce C Niland; Richard Theriault; Stephen B Edge; Douglas Blayney; Jane C Weeks
Journal:  Oncologist       Date:  2011-03-30

4.  The effect of age on delay in diagnosis and stage of breast cancer.

Authors:  Ann H Partridge; Melissa E Hughes; Rebecca A Ottesen; Yu-Ning Wong; Stephen B Edge; Richard L Theriault; Douglas W Blayney; Joyce C Niland; Eric P Winer; Jane C Weeks; Rulla M Tamimi
Journal:  Oncologist       Date:  2012-05-03

5.  Leveraging Digital Data to Inform and Improve Quality Cancer Care.

Authors:  Tina Hernandez-Boussard; Douglas W Blayney; James D Brooks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-17       Impact factor: 4.254

6.  Time to diagnosis and breast cancer stage by race/ethnicity.

Authors:  Erica T Warner; Rulla M Tamimi; Melissa E Hughes; Rebecca A Ottesen; Yu-Ning Wong; Stephen B Edge; Richard L Theriault; Douglas W Blayney; Joyce C Niland; Eric P Winer; Jane C Weeks; Ann H Partridge
Journal:  Breast Cancer Res Treat       Date:  2012-10-26       Impact factor: 4.872

7.  Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

Authors:  Michael J Hassett; Melissa E Hughes; Joyce C Niland; Stephen B Edge; Richard L Theriault; Yu-Ning Wong; John Wilson; W Bradford Carter; Douglas W Blayney; Jane C Weeks
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

8.  Selecting high priority quality measures for breast cancer quality improvement.

Authors:  Michael J Hassett; Melissa E Hughes; Joyce C Niland; Rebecca Ottesen; Stephen B Edge; Michael A Bookman; Robert W Carlson; Richard L Theriault; Jane C Weeks
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

9.  Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome.

Authors:  Jennifer M Matro; Tianyu Li; Massimo Cristofanilli; Melissa E Hughes; Rebecca A Ottesen; Jane C Weeks; Yu-Ning Wong
Journal:  Clin Breast Cancer       Date:  2014-06-23       Impact factor: 3.225

10.  Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.

Authors:  Rinaa S Punglia; Melissa E Hughes; Stephen B Edge; Richard L Theriault; Michael A Bookman; John L Wilson; Rebecca A Ottesen; Joyce C Niland; Jane C Weeks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-28       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.